Product profile · United States

ABILIFY MYCITE KIT

· Patent Litigation & Settlement History ↓

IngredientARIPIPRAZOLE

Application typeNDA

Application207202

Product004

Dosage formTABLET

RouteORAL

Strength15MG

Approval date2017-11-13

Marketing statusDiscontinued

Status event—

ApplicantOTSUKA

Product source

Current GenericRadar decision

Year—

SelectionDISCONTINUED

ReviewFINAL

Anchor typeDISCONTINUATION

Anchor date—

Patent anchor—

Exclusivity anchor—

Protection date—

First Final ANDA—

Status event—

Discontinued in the original 2026-10-10 source. Actual marketing-discontinuation date is unverified. Evidence limits: actual discontinuation date unavailable; do not substitute the observation date or approval year.

Patent estate

Patent	Effective date	Official listing	TRUE_DS	DS grade	Claim classification / basis	PTE	PED	Family
11476952	2026-04-28	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
11476952	2026-04-28	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9125939	2026-07-28	U U-1749	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9125939	2026-07-28	U U-1749	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
7978064	2026-09-14	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
7978064	2026-09-14	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8759350	2027-03-02	U U-1529	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8759350	2027-03-02	U U-1529	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9444503	2027-11-19	DP/U U-2169	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9444503	2027-11-19	DP/U U-2169	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9119554	2028-12-16	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9119554	2028-12-16	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9060708	2029-03-05	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9060708	2029-03-05	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9258035	2029-03-05	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9258035	2029-03-05	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8674825	2029-04-09	DP/U U-2170	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8674825	2029-04-09	DP/U U-2170	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8956288	2029-07-06	DP/U U-2167	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8956288	2029-07-06	DP/U U-2167	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
10441194	2029-07-26	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
10441194	2029-07-26	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8945005	2029-08-19	DP/U U-2167	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8945005	2029-08-19	DP/U U-2167	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9433371	2029-09-15	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9433371	2029-09-15	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8718193	2029-12-05	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8718193	2029-12-05	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9149577	2029-12-15	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9149577	2029-12-15	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8847766	2030-03-29	DP/U U-2167	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8847766	2030-03-29	DP/U U-2167	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8545402	2030-04-27	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8545402	2030-04-27	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8114021	2030-06-21	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8114021	2030-06-21	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
11464423	2030-09-15	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
11464423	2030-09-15	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9941931	2030-11-04	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9941931	2030-11-04	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8961412	2030-11-17	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8961412	2030-11-17	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8258962	2030-11-25	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8258962	2030-11-25	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8547248	2030-12-18	DP/U U-2167	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
8547248	2030-12-18	DP/U U-2167	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
11229378	2031-07-11	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
11229378	2031-07-11	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9320455	2031-12-15	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9320455	2031-12-15	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
10517507	2032-06-13	DP —	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
10517507	2032-06-13	DP —	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9268909	2033-10-15	DP/U U-2168	—	—	— [GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—
9268909	2033-10-15	DP/U U-2168	—	—	— Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	—	—	—

Regulatory exclusivity

Code	Start date	End date	Scope	Entire product	All indications	Full coverage date	Combination	Source
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · CURRENT_SNAPSHOT_NO_RECORD · Historical coverage: NOT_COMPLETE

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / product	Event	Final date	Tentative date	Applicant	Authorized generic	Exact mapping	Source
078613 / 004	APPLICATION_TENTATIVE_OBSERVATION · TENTATIVE_PRODUCT_SCOPE_UNVERIFIED	—	—	BARR LABS INC	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
078614 / 003	APPLICATION_TENTATIVE_OBSERVATION · TENTATIVE_PRODUCT_SCOPE_UNVERIFIED	—	—	SUN PHARMA GLOBAL	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
208260 / 004	APPLICATION_TENTATIVE_OBSERVATION · TENTATIVE_PRODUCT_SCOPE_UNVERIFIED	—	—	PHARMTAK INC	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
078708 / 001	FINAL_APPROVAL · FINAL_APPROVED	2015-04-28	—	TEVA PHARMACEUTICALS USA	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
201519 / 004	FINAL_APPROVAL · FINAL_APPROVED	2015-04-28	—	TORRENT PHARMACEUTICALS LTD	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
202101 / 004	FINAL_APPROVAL · FINAL_APPROVED	2015-04-28	—	ALEMBIC PHARMACEUTICALS LTD	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
205064 / 004	FINAL_APPROVAL · FINAL_APPROVED	2015-04-28	—	HETERO LABS LTD UNIT V	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
078583 / 004	FINAL_APPROVAL · FINAL_APPROVED	2015-07-24	—	APOTEX INC	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
203908 / 004	FINAL_APPROVAL · FINAL_APPROVED	2015-10-08	—	AUROBINDO PHARMA LTD	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
204838 / 004	FINAL_APPROVAL · FINAL_APPROVED	2016-06-17	—	AMNEAL PHARMACEUTICALS	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
206174 / 004	FINAL_APPROVAL · FINAL_APPROVED	2016-09-12	—	AJANTA PHARMA LTD	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
206383 / 004	FINAL_APPROVAL · FINAL_APPROVED	2016-09-29	—	SCIEGEN PHARMACEUTICALS INC	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
204111 / 004	FINAL_APPROVAL · FINAL_APPROVED	2016-10-07	—	MACLEODS PHARMACEUTICALS LTD	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
206251 / 004	FINAL_APPROVAL · FINAL_APPROVED	2016-12-07	—	ACCORD HEALTHCARE INC	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
091279 / 004	FINAL_APPROVAL · FINAL_APPROVED	2017-01-09	—	AIPING PHARMACEUTICAL INC	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
202683 / 004	FINAL_APPROVAL · FINAL_APPROVED	2017-05-23	—	ORBION PHARMACEUTICALS PRIVATE LTD	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
205363 / 004	FINAL_APPROVAL · FINAL_APPROVED	2017-12-04	—	PRINSTON PHARMACEUTICAL INC	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
206240 / 004	FINAL_APPROVAL · FINAL_APPROVED	2018-09-19	—	RISING PHARMA HOLDINGS INC	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
090472 / 004	FINAL_APPROVAL · FINAL_APPROVED	2019-01-07	—	ZYDUS PHARMACEUTICALS USA INC	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
207105 / 004	FINAL_APPROVAL · FINAL_APPROVED	2019-02-21	—	ALKEM LABORATORIES LTD	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
203025 / 004	FINAL_APPROVAL · FINAL_APPROVED	2021-12-01	—	UNICHEM LABORATORIES LTD	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source
205589 / 004	FINAL_APPROVAL · FINAL_APPROVED	2024-03-18	—	LUPIN INC	N	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

API	Holder / manufacturer	Holder country	Filing type	Number	Status	Filed date	Available for reference	Source	Last verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / product	Applicant	Event / status	First marketed	Product mapping	Source	Last verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / product	Applicant	Event / status	Tentative date	Follow-up final approval	Product mapping	Source	Last verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / product	Applicant	Event / status	Certification event date	Product mapping	Source	Last verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 19 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / product	Applicant	Event / status	Final approval date	Product mapping	Source	Last verified
078708 / 001	TEVA PHARMACEUTICALS USA	FINAL_APPROVAL · FINAL_APPROVED	2015-04-28	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
201519 / 004	TORRENT PHARMACEUTICALS LTD	FINAL_APPROVAL · FINAL_APPROVED	2015-04-28	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
202101 / 004	ALEMBIC PHARMACEUTICALS LTD	FINAL_APPROVAL · FINAL_APPROVED	2015-04-28	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
205064 / 004	HETERO LABS LTD UNIT V	FINAL_APPROVAL · FINAL_APPROVED	2015-04-28	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
078583 / 004	APOTEX INC	FINAL_APPROVAL · FINAL_APPROVED	2015-07-24	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
203908 / 004	AUROBINDO PHARMA LTD	FINAL_APPROVAL · FINAL_APPROVED	2015-10-08	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
204838 / 004	AMNEAL PHARMACEUTICALS	FINAL_APPROVAL · FINAL_APPROVED	2016-06-17	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
206174 / 004	AJANTA PHARMA LTD	FINAL_APPROVAL · FINAL_APPROVED	2016-09-12	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
206383 / 004	SCIEGEN PHARMACEUTICALS INC	FINAL_APPROVAL · FINAL_APPROVED	2016-09-29	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
204111 / 004	MACLEODS PHARMACEUTICALS LTD	FINAL_APPROVAL · FINAL_APPROVED	2016-10-07	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
206251 / 004	ACCORD HEALTHCARE INC	FINAL_APPROVAL · FINAL_APPROVED	2016-12-07	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
091279 / 004	AIPING PHARMACEUTICAL INC	FINAL_APPROVAL · FINAL_APPROVED	2017-01-09	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
202683 / 004	ORBION PHARMACEUTICALS PRIVATE LTD	FINAL_APPROVAL · FINAL_APPROVED	2017-05-23	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
205363 / 004	PRINSTON PHARMACEUTICAL INC	FINAL_APPROVAL · FINAL_APPROVED	2017-12-04	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
206240 / 004	RISING PHARMA HOLDINGS INC	FINAL_APPROVAL · FINAL_APPROVED	2018-09-19	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
090472 / 004	ZYDUS PHARMACEUTICALS USA INC	FINAL_APPROVAL · FINAL_APPROVED	2019-01-07	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
207105 / 004	ALKEM LABORATORIES LTD	FINAL_APPROVAL · FINAL_APPROVED	2019-02-21	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
203025 / 004	UNICHEM LABORATORIES LTD	FINAL_APPROVAL · FINAL_APPROVED	2021-12-01	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—
205589 / 004	LUPIN INC	FINAL_APPROVAL · FINAL_APPROVED	2024-03-18	EXACT_PRODUCT · PENDING_PRODUCT_MAPPING	Source	—

Decision evidence (27)

Type	Date	Role	Basis	Source
PATENT	2026-04-28	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2026-07-28	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2026-09-14	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2027-03-02	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2027-11-19	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2028-12-16	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2029-03-05	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2029-03-05	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2029-04-09	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2029-07-06	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2029-07-26	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2029-08-19	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2029-09-15	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2029-12-05	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2029-12-15	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2030-03-29	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2030-04-27	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2030-06-21	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2030-09-15	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2030-11-04	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2030-11-17	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2030-11-25	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2030-12-18	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2031-07-11	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2031-12-15	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2032-06-13	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source
PATENT	2033-10-15	LISTING_CONTEXT	Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.	Source

Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.